2024-03-28T10:27:15Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_2BC44A699A59
2024-03-23T02:05:24Z
serval:BIB_2BC44A699A59
Pattern of Care Study in Metastatic Renal-Cell Carcinoma in the Preimmunotherapy Era in Switzerland.
10.1016/j.clgc.2018.01.002
000439486400002
29503245
Sandmeier
N.
author
Rothschild
S.I.
author
Rothermundt
C.
author
Cathomas
R.
author
Schardt
J.
author
Berthold
D.
author
von Burg
P.
author
Müller
B.
author
Beyer
J.
author
Vogt
D.R.
author
Stenner
F.
author
article
2018-08
Clinical genitourinary cancer
1938-0682
1558-7673
journal
16
4
e711-e718
Algorithms
Antineoplastic Agents/therapeutic use
Carcinoma, Renal Cell/drug therapy
Carcinoma, Renal Cell/surgery
Delivery of Health Care/methods
Female
Humans
Kidney Neoplasms/drug therapy
Kidney Neoplasms/surgery
Male
Middle Aged
Molecular Targeted Therapy/methods
Neoplasm Metastasis
Patient Outcome Assessment
Retrospective Studies
Survival Analysis
Switzerland
Treatment Outcome
Sequential therapy in mRCC, Swiss mRCC cohort
Tyrosine kinase inhibitor (TKI)
VEGF-targeted therapy
mTOR inhibitors
eng
60_published
peer-reviewed
Publication types: Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish